Accelerated vascular disease in systemic lupus erythematosus: role of macrophage

Area of Science:

• Immunology and Cardiovascular Science
• Focus on macrophage biology in inflammatory diseases

Background:

• Atherosclerosis is a leading cause of global mortality, characterized by chronic inflammation.
• Systemic lupus erythematosus (SLE) patients exhibit a high incidence of atherosclerosis, often at a younger age.
• Macrophages are key immune cells involved in lipid metabolism and inflammatory responses central to atherosclerosis development.

Purpose of the Study:

• To review the multifaceted role of macrophages in atherosclerosis, particularly within the context of SLE.
• To explore intrinsic macrophage-derived factors and extrinsic influences modulating macrophage behavior in SLE-associated atherosclerosis.
• To elucidate mechanisms underlying accelerated atherosclerosis development in SLE patients.

Main Methods:

• Comprehensive literature review focusing on macrophage function in atherosclerosis.
• Analysis of studies investigating the interplay between SLE pathogenesis and cardiovascular disease.
• Synthesis of current knowledge on factors influencing macrophage behavior in inflammatory conditions.

Main Results:

• Macrophages contribute significantly to atherosclerotic plaque formation, inflammation, and rupture through lipid scavenging and cytokine secretion.
• Activated macrophages can induce apoptosis in surrounding cells, exacerbating tissue damage.
• Specific factors, both from macrophages and external to them, are implicated in the heightened atherosclerosis risk in SLE.

Conclusions:

• Macrophages are critical players in the accelerated development of atherosclerosis observed in systemic lupus erythematosus (SLE).
• Understanding the complex interactions of macrophage-derived and extrinsic factors is crucial for addressing SLE-associated cardiovascular risks.
• Further research into macrophage behavior in SLE is warranted to develop targeted therapeutic strategies.